Philip Morris stock holds close to $192 as smoke-free products gain traction
Published on 08/29/2026 at 13:30 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Philip Morris International (ISIN US7181721090) stock traded at $191.89 at the close of August 28, 2026, reflecting a 0.74% gain on the day as the company continues to expand its smoke-free portfolio.
Stock price and recent performance
According to a recent market overview Philip Morris shares finished the regular New York Stock Exchange session on August 28, 2026 at $191.89, up $1.41 or 0.74% from the prior close href='https://finance.yahoo.com/quote/PM/earnings-calls/' title='Philip Morris stock quote and earnings overview'>recent quote data. Intraday data show that the stock traded modestly higher in after-hours activity, reaching $192.51 later that evening, which adds a small additional gain of 0.32% on top of the regular-session advance href='https://finance.yahoo.com/quote/PM/earnings-calls/' title='Philip Morris stock intraday performance snapshot'>after-hours trading snapshot.
A separate price listing shows Philip Morris at a spot price of $191.89 with a daily increase of $1.41, matching the 0.74% advance and reinforcing the consistency of the recent closing level href='https://www.investing.com/equities/philip-morris-intl-candlestick' title='Philip Morris candlestick chart and daily change'>candlestick chart data. This convergence across quote feeds means investors can use the $191.89 level as a reliable reference point for evaluating the latest move.
Valuation and analyst view
A valuation analysis published on August 28, 2026 highlighted that Philip Morris shares were trading at $190.72 at the time of that assessment, while an estimated fair value for the stock stood at $158.16 href='https://www.gurufocus.com/news/9058167/pm-looks-206-overvalued-on-gf-value-as-dividend-sustainability-faces-scrutiny' title='GF Value assessment of Philip Morris valuation and dividend risk'>valuation assessment report. The difference between these figures implies that the stock price exceeded this fair-value estimate by 20.6%, suggesting a premium valuation relative to that particular model.
The same analysis raised questions about dividend sustainability, pairing the 20.6% premium with concerns that investors are paying a higher multiple for what has historically been a dividend-focused name href='https://www.gurufocus.com/news/9058167/pm-looks-206-overvalued-on-gf-value-as-dividend-sustainability-faces-scrutiny' title='Dividend sustainability discussion and valuation context for Philip Morris'>dividend sustainability discussion. For income-oriented shareholders, the combination of a premium price and a focus on dividend safety has become a key part of the investment narrative.
Other coverage points out that Philip Morris currently carries a Moderate Buy consensus rating with an average price target of $205.89 per share, which stands above both the recent $191.89 close and the $190.72 valuation snapshot level href='https://www.marketbeat.com/instant-alerts/filing-252107-shares-in-philip-morris-international-inc-pm-bought-by-beacon-pointe-advisors-llc-2026-08-29/' title='Analyst consensus rating and average price target summary for Philip Morris'>analyst consensus overview. The spread between the $205.89 target and the latest closing price of $191.89 indicates room of $14.00 per share, or 7.3%, to reach the average target if that view holds.
Institutional trading activity
Recent institutional filings as of August 29, 2026 show that one advisory firm reported a new position totaling 252,107 Philip Morris shares, indicating fresh interest from professional investors at current price levels href='https://www.marketbeat.com/instant-alerts/filing-252107-shares-in-philip-morris-international-inc-pm-bought-by-beacon-pointe-advisors-llc-2026-08-29/' title='Institutional filing reporting a new Philip Morris share position'>institutional position filing. At a reference price close to $192, such a holding would represent a transaction value in the tens of millions of dollars.
Another filing released on August 29, 2026 described a financial institution initiating a position of $1.18 million in Philip Morris shares, underlining that the stock remains actively traded among banks and asset managers href='https://www.marketbeat.com/instant-alerts/filing-field-main-bank-takes-118-million-position-in-philip-morris-international-inc-pm-2026-08-29/' title='New institutional stake disclosure in Philip Morris'>new institutional stake disclosure. At the same time, yet another asset manager reported reducing its holdings, demonstrating that the latest move higher in the share price has been accompanied by both buyers and sellers adjusting their exposures href='https://www.marketbeat.com/instant-alerts/filing-ferguson-wellman-capital-management-inc-reduces-stock-holdings-in-philip-morris-international-inc-pm-2026-08-29/' title='Institutional filing detailing reduced Philip Morris holdings'>institutional reduction filing.
For individual investors, this mix of new positions and partial exits from institutional holders provides a quantitative signal that the current price in the low $190s is an active area for portfolio rebalancing. The filings also complement the valuation and analyst data, painting a fuller picture of how different market participants view the stock at current levels.
Regulatory backdrop for smoke-free products
On the regulatory front, a recent update on August 28, 2026 reported that the United States Food and Drug Administration allowed marketing of new electronic cigarettes and flavored pods from a prominent vaping company, while also clearing other smoke-free nicotine products such as the ZYN Ultra nicotine pouches produced under the Philip Morris umbrella href='https://kfgo.com/2026/08/28/fda-allows-marketing-of-juuls-new-e-cigarettes-and-flavored-pods/' title='Regulatory update on smoke-free nicotine products including ZYN Ultra'>regulatory update on smoke-free products. This decision supports the broader shift in the nicotine market from traditional combustible cigarettes toward alternative delivery systems.
While the FDA action was specific to certain products, inclusion of ZYN Ultra among the cleared smoke-free nicotine products signals a more permissive environment for modern oral and smoke-free offerings associated with Philip Morris href='https://kfgo.com/2026/08/28/fda-allows-marketing-of-juuls-new-e-cigarettes-and-flavored-pods/' title='Coverage of FDA decision affecting ZYN Ultra and related products'>coverage of FDA decision. For the company, regulatory steps that allow commercialization of such products in key markets can strengthen the growth potential of its smoke-free portfolio, which has been central to its medium-term strategy.
Investors often look at these regulatory milestones as forward-looking indicators. Approvals or marketing authorizations for smoke-free products can enhance revenue diversification and help offset volume declines in traditional cigarettes, especially when supported by strong distribution networks and brand recognition.
Product spotlight ZYN Ultra nicotine pouches
Within Philip Morris International's smoke-free range, ZYN Ultra nicotine pouches stand out as a representative product that reflects the company focus on reduced-risk offerings. ZYN Ultra is designed as a smokeless, spit-free pouch placed under the upper lip, delivering nicotine without combustion or vapor, appealing to adult consumers seeking discreet usage and alternative formats.
The product has been positioned in various markets as part of a broader harm reduction strategy, in which nicotine is provided without the tar and many of the combustion-related toxicants found in conventional cigarettes. In conjunction with other reduced-risk products, ZYN Ultra helps Philip Morris address changing consumer preferences and regulatory pressure on smoking, while maintaining revenue from nicotine categories.
Current trading context for Philip Morris stock
As of the close on August 28, 2026, Philip Morris stock trades at $191.89 on the New York Stock Exchange in U.S. dollars, with a same-day gain of 0.74% compared with the previous session. The combination of a premium valuation signal, an average analyst target of $205.89, and active institutional flows suggests that the low $190s area is a key reference zone for assessing the next medium-term move in the shares.
Fact box
Company Philip Morris International Inc.
ISIN US7181721090
Ticker PM
Exchange New York Stock Exchange (primary listing)
Price (as of August 28, 2026, 4:00 p.m. ET) $191.89 USD
Sector / Industry Tobacco and smoke-free nicotine products
